2006 Pharmaceutical Companies Vaccines 
Roots Analysis
FEBRUARY 26, 2024
In fact, the share of biologics in the overall pharmaceutical contract manufacturing market has increased from 16% in 2006 to over 25% in 2017. Having reported over 70% increase in revenues over the past 5-6 years, the market for biologically derived products is currently estimated to be worth more than USD 200 billion.
pharmaphorum
SEPTEMBER 18, 2020
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaShots
APRIL 13, 2023
model is a holistic approach to incorporate the same strategy to life science and pharmaceutical companies. A globally fast-growing, and largest pharmaceutical company in the world was created through a merger between Pfizer and Pharmacia. by the sales of Humira 2006 Johnson & Johnson recorded global sales of $53.3B
pharmaphorum
DECEMBER 2, 2020
One thing that highlighted this changed focus was the appointment of Kindler as CEO in 2006. In 2014 the company made an offer of around $100 billion to acquire UK firm AstraZeneca (which at the time was going through a rough patch ).
Pharmaceutical Technology
AUGUST 26, 2008
It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals. As understanding of biological systems has forged ahead, pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines.
Pharmaceutical Technology
JULY 23, 2008
The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. “Companies used to be universally protected by patents but there is a pathway to approval opening up for biosimilar legislation. .”
PharmaShots
FEBRUARY 21, 2023
Market Cap: $82.80M Founded Year: 2001 Total Employees: ~70 Headquarters: Kawasaki, Japan Stock Exchange: TYO OncoTherapy Science is a biotech company focused on developing novel molecular-targeted anti-cancer drugs using its own technologies. In 2021, Telix generated total revenue of $7.59M from the sales of its radiopharma products.
Expert insights. Personalized for you.
52 
Let's personalize your content